BA
NUVA

Boston Advisors’s NuVasive, Inc. NUVA Stock Holding History

Boston Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.5M Buy
39,438
+12,908
+49% +$807K 0.13% 209
2019
Q2 		$1.55M Buy
26,530
+3,547
+15% +$209K 0.08% 262
2019
Q1 		$1.3M Buy
+22,983
New +$1.22M 0.07% 296

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Advisors's NUVA Position: Q3 2019 in Review

Boston Advisors increased its NuVasive, Inc. (NUVA) stake by 49% in Q3 2019, buying an estimated $807K and bringing the position to 39,438 shares worth $2.5M. The position accounts for 0.13% of the portfolio, ranked #209.

Boston Advisors first reported a position in NUVA in Q1 2019 and has held it in 3 quarters since. 262 funds tracked by Wall St. Rank hold NUVA as of Q3 2019.

  • Boston Advisors held 39,438 shares of NuVasive, Inc. worth $2.5M as of Q3 2019.
  • Boston Advisors bought 12,908 NuVasive, Inc. shares in Q3 2019, an estimated $807K.
  • NuVasive, Inc. made up 0.13% of Boston Advisors's portfolio in Q3 2019, its #209 holding.
  • Boston Advisors first reported a position in NuVasive, Inc. in Q1 2019 and has held it in 3 quarters since.
  • 262 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.